aluates Reports

$ 0.0

Automative

Global Genital Herpes Vaccine Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-34Q13547

Global Genital Herpes Vaccine Market Research Report 2023

BUY CHAPTERS

Global Genital Herpes Vaccine Market Research Report 2025

Code: QYRE-Auto-34Q13547

Report

May 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

BioNTech

Beike Bio

Changsheng Biotechnology

GSK

Genital Herpes Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Genital Herpes Vaccine Market

The global market for Genital Herpes Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Genital Herpes Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genital Herpes Vaccine.

The Genital Herpes Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genital Herpes Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genital Herpes Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Genital Herpes Vaccine Market Report

Report Metric	Details
Report Name	Genital Herpes Vaccine Market
CAGR	5%
Segment by Type	Zoster Vaccine Live Recombinant Zoster Vaccine
Segment by Application	Male Female
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GSK, Merck, BioNTech, Beike Bio, Changsheng Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genital Herpes Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genital Herpes Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Genital Herpes Vaccine Market report?

Ans: The main players in the Genital Herpes Vaccine Market are GSK, Merck, BioNTech, Beike Bio, Changsheng Biotechnology

What are the Application segmentation covered in the Genital Herpes Vaccine Market report?

Ans: The Applications covered in the Genital Herpes Vaccine Market report are Male, Female

What are the Type segmentation covered in the Genital Herpes Vaccine Market report?

Ans: The Types covered in the Genital Herpes Vaccine Market report are Zoster Vaccine Live, Recombinant Zoster Vaccine

Recommended Reports

Infectious Disease Vaccines

Vaccine Technologies

Vaccine Devices & Delivery

1 Genital Herpes Vaccine Market Overview

1.1 Product Definition

1.2 Genital Herpes Vaccine by Type

1.2.1 Global Genital Herpes Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Zoster Vaccine Live

1.2.3 Recombinant Zoster Vaccine

1.3 Genital Herpes Vaccine by Application

1.3.1 Global Genital Herpes Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Male

1.3.3 Female

1.4 Global Genital Herpes Vaccine Market Size Estimates and Forecasts

1.4.1 Global Genital Herpes Vaccine Revenue 2020-2031

1.4.2 Global Genital Herpes Vaccine Sales 2020-2031

1.4.3 Global Genital Herpes Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Genital Herpes Vaccine Market Competition by Manufacturers

2.1 Global Genital Herpes Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Genital Herpes Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Genital Herpes Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Genital Herpes Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Genital Herpes Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Genital Herpes Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Genital Herpes Vaccine, Date of Enter into This Industry

2.8 Global Genital Herpes Vaccine Market Competitive Situation and Trends

2.8.1 Global Genital Herpes Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Genital Herpes Vaccine Players Market Share by Revenue

2.8.3 Global Genital Herpes Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Genital Herpes Vaccine Market Scenario by Region

3.1 Global Genital Herpes Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Genital Herpes Vaccine Sales by Region: 2020-2031

3.2.1 Global Genital Herpes Vaccine Sales by Region: 2020-2025

3.2.2 Global Genital Herpes Vaccine Sales by Region: 2026-2031

3.3 Global Genital Herpes Vaccine Revenue by Region: 2020-2031

3.3.1 Global Genital Herpes Vaccine Revenue by Region: 2020-2025

3.3.2 Global Genital Herpes Vaccine Revenue by Region: 2026-2031

3.4 North America Genital Herpes Vaccine Market Facts & Figures by Country

3.4.1 North America Genital Herpes Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Genital Herpes Vaccine Sales by Country (2020-2031)

3.4.3 North America Genital Herpes Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Genital Herpes Vaccine Market Facts & Figures by Country

3.5.1 Europe Genital Herpes Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Genital Herpes Vaccine Sales by Country (2020-2031)

3.5.3 Europe Genital Herpes Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Genital Herpes Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Genital Herpes Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Genital Herpes Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Genital Herpes Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Genital Herpes Vaccine Market Facts & Figures by Country

3.7.1 Latin America Genital Herpes Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Genital Herpes Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Genital Herpes Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Genital Herpes Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Genital Herpes Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Genital Herpes Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Genital Herpes Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Genital Herpes Vaccine Sales by Type (2020-2031)

4.1.1 Global Genital Herpes Vaccine Sales by Type (2020-2025)

4.1.2 Global Genital Herpes Vaccine Sales by Type (2026-2031)

4.1.3 Global Genital Herpes Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Genital Herpes Vaccine Revenue by Type (2020-2031)

4.2.1 Global Genital Herpes Vaccine Revenue by Type (2020-2025)

4.2.2 Global Genital Herpes Vaccine Revenue by Type (2026-2031)

4.2.3 Global Genital Herpes Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Genital Herpes Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Genital Herpes Vaccine Sales by Application (2020-2031)

5.1.1 Global Genital Herpes Vaccine Sales by Application (2020-2025)

5.1.2 Global Genital Herpes Vaccine Sales by Application (2026-2031)

5.1.3 Global Genital Herpes Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Genital Herpes Vaccine Revenue by Application (2020-2031)

5.2.1 Global Genital Herpes Vaccine Revenue by Application (2020-2025)

5.2.2 Global Genital Herpes Vaccine Revenue by Application (2026-2031)

5.2.3 Global Genital Herpes Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Genital Herpes Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 GSK

6.1.1 GSK Company Information

6.1.2 GSK Description and Business Overview

6.1.3 GSK Genital Herpes Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GSK Genital Herpes Vaccine Product Portfolio

6.1.5 GSK Recent Developments/Updates

6.2 Merck

6.2.1 Merck Company Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Genital Herpes Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Merck Genital Herpes Vaccine Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 BioNTech

6.3.1 BioNTech Company Information

6.3.2 BioNTech Description and Business Overview

6.3.3 BioNTech Genital Herpes Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 BioNTech Genital Herpes Vaccine Product Portfolio

6.3.5 BioNTech Recent Developments/Updates

6.4 Beike Bio

6.4.1 Beike Bio Company Information

6.4.2 Beike Bio Description and Business Overview

6.4.3 Beike Bio Genital Herpes Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Beike Bio Genital Herpes Vaccine Product Portfolio

6.4.5 Beike Bio Recent Developments/Updates

6.5 Changsheng Biotechnology

6.5.1 Changsheng Biotechnology Company Information

6.5.2 Changsheng Biotechnology Description and Business Overview

6.5.3 Changsheng Biotechnology Genital Herpes Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Changsheng Biotechnology Genital Herpes Vaccine Product Portfolio

6.5.5 Changsheng Biotechnology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Genital Herpes Vaccine Industry Chain Analysis

7.2 Genital Herpes Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Genital Herpes Vaccine Production Mode & Process Analysis

7.4 Genital Herpes Vaccine Sales and Marketing

7.4.1 Genital Herpes Vaccine Sales Channels

7.4.2 Genital Herpes Vaccine Distributors

7.5 Genital Herpes Vaccine Customer Analysis

8 Genital Herpes Vaccine Market Dynamics

8.1 Genital Herpes Vaccine Industry Trends

8.2 Genital Herpes Vaccine Market Drivers

8.3 Genital Herpes Vaccine Market Challenges

8.4 Genital Herpes Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

BioNTech

Beike Bio

Changsheng Biotechnology

GSK

List of Tables

Table 1. Global Genital Herpes Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Genital Herpes Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Genital Herpes Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Genital Herpes Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Genital Herpes Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Genital Herpes Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Genital Herpes Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Genital Herpes Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Genital Herpes Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Genital Herpes Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Genital Herpes Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Genital Herpes Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Genital Herpes Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Genital Herpes Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Genital Herpes Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global Genital Herpes Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Genital Herpes Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global Genital Herpes Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Genital Herpes Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Genital Herpes Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Genital Herpes Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Genital Herpes Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Genital Herpes Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Genital Herpes Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America Genital Herpes Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America Genital Herpes Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Genital Herpes Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Genital Herpes Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Genital Herpes Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Genital Herpes Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Genital Herpes Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Genital Herpes Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Genital Herpes Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Genital Herpes Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Genital Herpes Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Genital Herpes Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Genital Herpes Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Genital Herpes Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Genital Herpes Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Genital Herpes Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Genital Herpes Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Genital Herpes Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Genital Herpes Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Genital Herpes Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Genital Herpes Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Genital Herpes Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Genital Herpes Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Genital Herpes Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global Genital Herpes Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global Genital Herpes Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Genital Herpes Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Genital Herpes Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Genital Herpes Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Genital Herpes Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Genital Herpes Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Genital Herpes Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global Genital Herpes Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global Genital Herpes Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global Genital Herpes Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global Genital Herpes Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Genital Herpes Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Genital Herpes Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Genital Herpes Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Genital Herpes Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Genital Herpes Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Genital Herpes Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global Genital Herpes Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. GSK Company Information

Table 71. GSK Description and Business Overview

Table 72. GSK Genital Herpes Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. GSK Genital Herpes Vaccine Product

Table 74. GSK Recent Developments/Updates

Table 75. Merck Company Information

Table 76. Merck Description and Business Overview

Table 77. Merck Genital Herpes Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Merck Genital Herpes Vaccine Product

Table 79. Merck Recent Developments/Updates

Table 80. BioNTech Company Information

Table 81. BioNTech Description and Business Overview

Table 82. BioNTech Genital Herpes Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. BioNTech Genital Herpes Vaccine Product

Table 84. BioNTech Recent Developments/Updates

Table 85. Beike Bio Company Information

Table 86. Beike Bio Description and Business Overview

Table 87. Beike Bio Genital Herpes Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Beike Bio Genital Herpes Vaccine Product

Table 89. Beike Bio Recent Developments/Updates

Table 90. Changsheng Biotechnology Company Information

Table 91. Changsheng Biotechnology Description and Business Overview

Table 92. Changsheng Biotechnology Genital Herpes Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Changsheng Biotechnology Genital Herpes Vaccine Product

Table 94. Changsheng Biotechnology Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Genital Herpes Vaccine Distributors List

Table 98. Genital Herpes Vaccine Customers List

Table 99. Genital Herpes Vaccine Market Trends

Table 100. Genital Herpes Vaccine Market Drivers

Table 101. Genital Herpes Vaccine Market Challenges

Table 102. Genital Herpes Vaccine Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Genital Herpes Vaccine

Figure 2. Global Genital Herpes Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Genital Herpes Vaccine Market Share by Type: 2024 & 2031

Figure 4. Zoster Vaccine Live Product Picture

Figure 5. Recombinant Zoster Vaccine Product Picture

Figure 6. Global Genital Herpes Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Genital Herpes Vaccine Market Share by Application: 2024 & 2031

Figure 8. Male

Figure 9. Female

Figure 10. Global Genital Herpes Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Genital Herpes Vaccine Market Size (2020-2031) & (US$ Million)

Figure 12. Global Genital Herpes Vaccine Sales (2020-2031) & (K Units)

Figure 13. Global Genital Herpes Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 14. Genital Herpes Vaccine Report Years Considered

Figure 15. Genital Herpes Vaccine Sales Share by Manufacturers in 2024

Figure 16. Global Genital Herpes Vaccine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Genital Herpes Vaccine Players: Market Share by Revenue in Genital Herpes Vaccine in 2024

Figure 18. Genital Herpes Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Genital Herpes Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Genital Herpes Vaccine Sales Market Share by Country (2020-2031)

Figure 21. North America Genital Herpes Vaccine Revenue Market Share by Country (2020-2031)

Figure 22. United States Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Genital Herpes Vaccine Sales Market Share by Country (2020-2031)

Figure 25. Europe Genital Herpes Vaccine Revenue Market Share by Country (2020-2031)

Figure 26. Germany Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Genital Herpes Vaccine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Genital Herpes Vaccine Revenue Market Share by Region (2020-2031)

Figure 33. China Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America Genital Herpes Vaccine Sales Market Share by Country (2020-2031)

Figure 41. Latin America Genital Herpes Vaccine Revenue Market Share by Country (2020-2031)

Figure 42. Mexico Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Middle East and Africa Genital Herpes Vaccine Sales Market Share by Country (2020-2031)

Figure 46. Middle East and Africa Genital Herpes Vaccine Revenue Market Share by Country (2020-2031)

Figure 47. Turkey Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. UAE Genital Herpes Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Global Sales Market Share of Genital Herpes Vaccine by Type (2020-2031)

Figure 51. Global Revenue Market Share of Genital Herpes Vaccine by Type (2020-2031)

Figure 52. Global Genital Herpes Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 53. Global Sales Market Share of Genital Herpes Vaccine by Application (2020-2031)

Figure 54. Global Revenue Market Share of Genital Herpes Vaccine by Application (2020-2031)

Figure 55. Global Genital Herpes Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 56. Genital Herpes Vaccine Value Chain

Figure 57. Channels of Distribution (Direct Vs Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Genital Herpes Treatment Drug Market Research Report 2025

Genital Herpes Research and Development Pipeline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Herpes Infection Treatment Market Research Report 2025

Global Viral Vaccines Market Research Report 2025

Viral Vector and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Shingles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

HPV Genetically Engineered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Viral Vaccine Media Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sexually Transmitted Diseases Drug Market Research Report 2025

mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Plant based Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaginitis Therapeutics Market Insights Forecast to 2030

Global Herpes Labialis Treatment Market Research Report 2024

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genetically Engineered Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions